27 unknown. 27 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 27 | Unknown 27 |
Follow Neuroectodermal Tumors: new trials by email Literature Review of Neuroectodermal Tumors trials Research Report on Neuroectodermal Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression CAR-T - Gliomas | Early Phase 1 | Unknown | JIANG LONGWEI | 3 | 2024-06-13 | 2025-02-14 |
| A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection - Recurrent Glioblastoma | Early Phase 1 | Unknown | Beijing Tsinghua Chang Gung Hospital | 22 | 2023-11-15 | 2023-08-25 |
| A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors Recombinant oncolytic herpes simplex virus type 1 (R130) - Sarcoma, Carcinoma | Early Phase 1 | Unknown | Shanghai Yunying Medical Technology | 20 | 2023-06-24 | 2023-07-27 |
| Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma Personalized drug combination - Recurrent Glioblastoma | Early Phase 1 | Unknown | Oslo University Hospital | 15 | 2023-03-01 | 2024-04-03 |
| The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study Saxenda - Panhypopituitarism, Craniopharyngioma | Early Phase 1 | Unknown | Seoul National University Hospital | 50 | 2022-11-28 | 2024-01-23 |
| Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme TMZ - Glioblastoma Multiforme | Early Phase 1 | Unknown | The Second Hospital of Hebei Medical University | 10 | 2022-10-01 | 2022-10-21 |
| 68Ga-NOTA-RM26 PET/CT in Glioma Patients 68Ga-RM26 - Glioma | Early Phase 1 | Unknown | Peking Union Medical College Hospital | 30 | 2022-10-01 | 2024-05-14 |
| The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme. Tumor Infiltrating Lymphocytes (TIL) - Glioblastoma Multiforme, Adult | Early Phase 1 | Unknown | Hebei Senlang Biotechnology Inc., Ltd. | 20 | 2022-02-15 | 2022-04-19 |
| Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases Autologous progenitor expansion -T, pemetrexed - Glioma, Brain Metastases | Early Phase 1 | Unknown | Shanghai Pudong Hospital | 30 | 2022-01-01 | 2022-07-15 |
| Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study Recombinant L-IFN adenovirus injection - Head and Neck Cancer, Melanoma | Early Phase 1 | Unknown | Shanghai Fengxian District Central Hospital | 28 | 2021-11-30 | 2022-02-01 |
| Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor Targeting CD276 CAR T cells - Osteosarcoma, Neuroblastoma | Early Phase 1 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 24 | 2021-05-14 | 2021-05-06 |
| Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors Gallium-68 NODAGA-JR11 - Neuroendocrine Tumors | Early Phase 1 | Unknown | First Affiliated Hospital of Fujian Medical University | 100 | 2020-12-01 | 2023-09-18 |
| Tumor Electric Fields Treatment System for Glioblastoma Tumor Electric Fields Treatment System - Glioblastoma | Early Phase 1 | Unknown | Xiangya Hospital of Central South University | 5 | 2020-04-07 | 2020-06-11 |
| FDG and FDOPA PET Demonstration of Functional Brain Abnormalities Positron Emission Tomography, Computed Tomography, Multiparametric Magnetic Resonance Imaging Scan - Glioblastoma | Early Phase 1 | Unknown | University of Virginia | 5 | 2020-03-15 | 2020-03-24 |
| CD147-CART Cells in Patients With Recurrent Malignant Glioma. CD147-CART - Recurrent Glioblastoma, CD147 Positive | Early Phase 1 | Unknown | Xijing Hospital | 31 | 2019-05-30 | 2020-05-07 |
| DNA Vaccination Against Neuroblastoma DNA vaccine, Salmonella oral vaccine, Lenalidomide - Relapsed Neuroblastoma | Early Phase 1 | Unknown | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | 12 | 2019-01-09 | 2022-03-02 |
| Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy GPA-TriMAR-T - Malignant Melanoma | Early Phase 1 | Unknown | Timmune Biotech Inc. | 6 | 2018-09-27 | 2019-12-06 |
| Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme TIL, PD1-TIL - Glioblastoma Multiforme | Early Phase 1 | Unknown | Huashan Hospital | 40 | 2017-01-01 | 2021-08-25 |
| Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging 68Ga-NOTA-3P-TATE-RGD - Lung Cancer, Neuroendocrine Neoplasm | Early Phase 1 | Unknown | Peking Union Medical College Hospital | 100 | 2016-06-01 | 2022-04-07 |
| The MetNET-2 Trial Lanreotide and Metformin - Neuroendocrine Tumors | Early Phase 1 | Unknown | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 20 | 2016-04-01 | 2021-06-07 |
Showing 20 of 27. Sign in to see all of them.
Glioblastoma (9) · Glioma (8) · Lung Neoplasms (4) · Melanoma (4) · Neuroendocrine Tumors (4) · Neuroblastoma (3) · Brain Neoplasms (2) · Breast Neoplasms (2) · Head and Neck Neoplasms (2) · Astrocytoma (1) · Carcinoma (1) · Combined Pituitary Hormone Deficiency (1) · Craniopharyngioma (1) · Gastrointestinal Neoplasms (1) · Kidney Neoplasms (1)
Neoplasms (27) · Neoplasms by Histologic Type (27) · Neoplasms, Germ Cell and Embryonal (27) · Neoplasms, Nerve Tissue (27) · Neoplasms, Glandular and Epithelial (19) · Neoplasms, Neuroepithelial (18) · Astrocytoma (9) · Glioma (7) · Neoplasms by Site (7) · Lung Diseases (4) · Neuroendocrine Tumors (4) · Nevi and Melanomas (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4)
Oncolytic Virotherapy (2) · 3-Iodobenzylguanidine (1) · 68Ga-NOTA-RM26 (1) · 68gallium-BNOTA-PRGD2 (1) · Fluorodeoxyglucose F18 (1) · Lenalidomide (1) · Liraglutide (1) · Magnetic Resonance Spectroscopy (1) · Metformin (1) · Pemetrexed (1) · Positron Emission Tomography Computed Tomography (1) · Rituximab (1) · Thiotepa (1) · Vaccines, DNA (1) · fludarabine (1)
Peking Union Medical College Hospital (5) · Beijing Tiantan Hospital (1) · Beijing Tsinghua Chang Gung Hospital (1) · Belarusian Research Center for Pediatric Oncology, Hematology and Immunology (1) · Cooperative Research Centre for Biomedical Imaging Development (1) · First Affiliated Hospital of Fujian Medical University (1) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Hebei Senlang Biotechnology Inc., Ltd. (1) · Huashan Hospital (1) · JIANG LONGWEI (1) · Lund University Hospital (1) · Oslo University Hospital (1) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1) · Seoul National University Hospital (1) · Shanghai Fengxian District Central Hospital (1)
China (17) · Australia (1) · Belarus (1) · France (1) · Italy (1) · Norway (1) · South Korea (1) · Sweden (1) · United States (1)
Bijoy Kundu, PhD (1) · Chunyan Li, Academician (1) · Chunyan Li, academician (1) · Einar O. Vik-Mo, MD, PhD (1) · Fang Li, Dr. (1) · Grant McArthur (1) · Haifeng Lin (1) · Inna V Proleskovskaya, PhD, MD (1) · Jacek Toporski, MD, PhD (1) · Jia Shaochang, doctor (1) · Jun Ren, MD,PhD (1) · Nan Ji, MD (1) · Rong Zhang, MD (1)
PMID 19660720, PMID 21252315, PMID 23112884, PMID 29307718, PMID 34146130, PMID 35657429, PMID 38719544, PMID 39806560, PMID 39821814, PMID 42556340
ZIAEB000073 (2)